HOX THERAPEUTICS LTD has a total of 23 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in EPO (European Patent Office), Brazil and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are KANAGAWA PREFECTURAL HOSPITAL ORGANIZATION, NAT CANCER CENTER JAPAN and CELLERANT THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Brazil | 2 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | United Kingdom | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Mexico | 2 | |
#8 | United States | 2 | |
#9 | WIPO (World Intellectual Property Organization) | 2 | |
#10 | Australia | 1 | |
#11 | Israel | 1 | |
#12 | New Zealand | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Morgan Richard | 17 |
#2 | Richard Morgan | 4 |
Publication | Filing date | Title |
---|---|---|
GB201615797D0 | Organic compounds | |
GB201518700D0 | Peptides |